|
AIDS cancer match, non-U.S.
|
Z01 CP010176-10084
|
$188,362
|
$18,836
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$9,624
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$3,519
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$45,450
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-07
|
$1,049,588
|
$20,992
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-20
|
$3,446,067
|
$379,067
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$727,646
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA014599-33
|
$4,263,552
|
$42,636
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-33S1
|
$80,979
|
$810
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer following bone-marrow transplantation
|
Z01 CP010131-04020
|
$144,313
|
$14,431
|
Ron, Elaine
|
DCEG (NCI)
|
|
Cancer following radiotherapy for benign gynecologic disorders
|
Z01 CP010131-04021
|
$3,528
|
$212
|
Ron, Elaine
|
DCEG (NCI)
|
|
Cancer risk among Japanese A-bomb survivors
|
Z01 CP010134-04016
|
$258,019
|
$12,901
|
Land, Charles
|
DCEG (NCI)
|
|
Cancer risk in x-ray technologists
|
Z01 CP010133-04180
|
$982,332
|
$19,647
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
|
Z01 BC 010630
|
$356,671
|
$107,002
|
Janik, John
|
CCR (NCI)
|
|
Childhood cancer study - Univ. of Minnesota
|
Z01 CP010131-04033
|
$321,079
|
$32,108
|
Ron, Elaine
|
DCEG (NCI)
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-14
|
$4,640,641
|
$464,064
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Children's Oncology Group Chair's Grant
|
2U10CA098543-06
|
$31,493,718
|
$5,038,995
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S1
|
|
$0
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S2
|
$18,805
|
$3,009
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S3
|
$750,000
|
$120,000
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
2U10CA098413-06
|
$5,717,149
|
$914,744
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
1R01CA131027-01A1
|
$308,743
|
$308,743
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
$1,081,661
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical Activity of MGCD-0103 in Hodgkin Lymphoma
|
1R21CA133876-01A1
|
$250,200
|
$250,200
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
CLL Families-Mayo
|
Z01 CP004410-10312
|
$218,599
|
$10,930
|
Tucker, Margaret
|
DCEG (NCI)
|
|
Clonal expansion of lymphocytes in multiple cohorts
|
Z01 CP010176-10092
|
$64,581
|
$3,229
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
COLUMBIA RIVER ONCOLOGY PROGRAM
|
5U10CA045377-22
|
$745,543
|
$14,911
|
LANIER, KEITH
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Community Clinical Oncology Program
|
5U10CA035431-25
|
$1,923,566
|
$38,471
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-07
|
$1,984,870
|
$317,579
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-25
|
$422,772
|
$67,644
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
|
3P30CA010815-39S2
|
$2,297,939
|
$68,938
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
|
3P30CA010815-39S3
|
$136,686
|
$4,101
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
|
3P30CA010815-39S4
|
$107,052
|
$3,212
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-22
|
$4,126,879
|
$82,538
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
$10,427
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Development of Recombinant Toxins to Treat Hematologic Malignancies
|
Z01 BC 010301
|
$558,572
|
$16,757
|
Kreitman, Robert
|
CCR (NCI)
|
|
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD
|
1R01CA133063-01A1
|
$274,204
|
$137,102
|
Longnecker, Richard
|
NORTHWESTERN UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-25
|
$798,586
|
$15,972
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
EBV Genome Expression:Localization of Specific Functions
|
5R01CA030356-27
|
$330,440
|
$33,044
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors
|
1R01CA133027-01
|
$300,378
|
$150,189
|
SUGDEN, WILLIAM
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Enhancing T Cell Therapy of Cancer
|
2P01CA094237-06
|
$1,905,870
|
$266,822
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
EORTC DATA CENTER
|
5U10CA011488-38
|
$793,241
|
$23,797
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-08
|
$726,878
|
$726,878
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-21
|
$543,770
|
$271,885
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Hodgkins disease for this search: $17,536,929
|